Filing Details
- Accession Number:
- 0000950170-24-115150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-16 21:25:42
- Reporting Period:
- 2024-10-16
- Accepted Time:
- 2024-10-16 21:25:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501796 | Aura Biosciences Inc. | AURA | Biological Products, (No Disgnostic Substances) (2836) | 320271970 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1868719 | Mark Plavsic | C/O Aura Biosciences, Inc. 80 Guest Street Boston MA 01235 | Chief Technology Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-10-16 | 7,383 | $9.85 | 121,132 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.
Billionaire Hedge Funds
